Source: The Hindu Business Line

Bharat Biotech: Bharat Biotech collaborates with Alopexx for anti-microbial vaccine

'As part of the collaboration, the companies will co-develop and commercialise AV0328, a synthetic vaccine targeting poly N-acetyl glucosamine (PNAG)'

Read full article »
Bharat Biotech's Competitors | Bharat Biotech's News | Bharat Biotech's Financials
Stay up-to-date with the latest news on Bharat Biotech
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Krishna Ella's photo - Managing Director of Bharat Biotech

Managing Director

Krishna Ella

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Bharat Biotech